Regulus Therapeutics Inc. Insider Trading for August 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Regulus Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Regulus Therapeutics Inc. for August 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.84 | 1,500 | 10,254 | 6,976,650 | 7 M to 7 M (-0.02 %) |
| Aug 29 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.96 | 2,000 | 13,921 | 6,978,150 | 7 M to 7 M (-0.03 %) |
| Aug 29 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.21 | 1,500 | 10,821 | 6,980,150 | 7 M to 7 M (-0.02 %) |
| Aug 29 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.84 | 1,500 | 10,254 | 6,077,650 | 6.1 M to 6.1 M (-0.02 %) |
| Aug 29 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.96 | 2,000 | 13,921 | 6,079,150 | 6.1 M to 6.1 M (-0.03 %) |
| Aug 29 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.21 | 1,500 | 10,821 | 6,081,150 | 6.1 M to 6.1 M (-0.02 %) |
| Aug 29 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Option Exercise | M | 0.38 | 3,505 | 1,332 | 455,297 | |
| Aug 29 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Sell | S | 7.06 | 3,505 | 24,754 | 0 | 3.5 K to 0 (-100.00 %) |
| Aug 29 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Buy | M | 0.38 | 3,505 | 1,332 | 3,505 | 0 to 3.5 K |
| Aug 22 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.75 | 5,250 | 35,443 | 6,082,650 | 6.1 M to 6.1 M (-0.09 %) |
| Aug 22 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.89 | 2,500 | 17,222 | 6,087,900 | 6.1 M to 6.1 M (-0.04 %) |
| Aug 22 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.14 | 3,000 | 21,424 | 6,090,400 | 6.1 M to 6.1 M (-0.05 %) |
| Aug 22 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.75 | 5,250 | 35,443 | 6,981,650 | 7 M to 7 M (-0.08 %) |
| Aug 22 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.89 | 2,500 | 17,222 | 6,986,900 | 7 M to 7 M (-0.04 %) |
| Aug 22 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.14 | 3,000 | 21,424 | 6,989,400 | 7 M to 7 M (-0.04 %) |
| Aug 15 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.98 | 1,450 | 10,115 | 6,093,400 | 6.1 M to 6.1 M (-0.02 %) |
| Aug 15 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.04 | 1,750 | 12,324 | 6,094,850 | 6.1 M to 6.1 M (-0.03 %) |
| Aug 15 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.02 | 2,250 | 15,788 | 6,096,600 | 6.1 M to 6.1 M (-0.04 %) |
| Aug 15 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.98 | 1,450 | 10,115 | 6,992,400 | 7 M to 7 M (-0.02 %) |
| Aug 15 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.04 | 1,750 | 12,324 | 6,993,850 | 7 M to 7 M (-0.03 %) |
| Aug 15 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.02 | 2,250 | 15,788 | 6,995,600 | 7 M to 7 M (-0.03 %) |
| Aug 08 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.80 | 1,850 | 12,583 | 6,997,850 | 7 M to 7 M (-0.03 %) |
| Aug 08 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.66 | 2,600 | 17,322 | 6,999,700 | 7 M to 7 M (-0.04 %) |
| Aug 08 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.08 | 3,150 | 22,300 | 7,002,300 | 7 M to 7 M (-0.04 %) |
| Aug 08 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.80 | 1,850 | 12,583 | 6,098,850 | 6.1 M to 6.1 M (-0.03 %) |
| Aug 08 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.66 | 2,600 | 17,322 | 6,100,700 | 6.1 M to 6.1 M (-0.04 %) |
| Aug 08 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.08 | 3,150 | 22,300 | 6,103,300 | 6.1 M to 6.1 M (-0.05 %) |
| Aug 07 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Option Exercise | M | 0.38 | 3,505 | 1,332 | 458,802 | |
| Aug 07 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Sell | S | 7.06 | 3,505 | 24,739 | 0 | 3.5 K to 0 (-100.00 %) |
| Aug 07 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President & CEO | Buy | M | 0.38 | 3,505 | 1,332 | 3,505 | 0 to 3.5 K |
| Aug 01 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.21 | 2,600 | 16,153 | 6,106,450 | 6.1 M to 6.1 M (-0.04 %) |
| Aug 01 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.42 | 1,750 | 11,235 | 6,109,050 | 6.1 M to 6.1 M (-0.03 %) |
| Aug 01 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.60 | 1,000 | 6,602 | 6,110,800 | 6.1 M to 6.1 M (-0.02 %) |
| Aug 01 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.21 | 2,600 | 16,153 | 7,005,450 | 7 M to 7 M (-0.04 %) |
| Aug 01 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.42 | 1,750 | 11,235 | 7,008,050 | 7 M to 7 M (-0.02 %) |
| Aug 01 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.60 | 1,000 | 6,602 | 7,009,800 | 7 M to 7 M (-0.01 %) |